Question

Two vaccines -- ALVAC from Sanofi Pasteur , the vaccine division of French drug company Sanofi Aventis , and AIDSVAX , originally developed by US-based VaxGen Inc. that is now owned by the non-profit Global Solutions for Infectious Diseases -- were used in the trial that targeted HIV strains circulating in Thailand .

Accepted Answer

Tayland' da dolaşan HIV türlerini hedef alan deneyde iki aşı - Fransız ilaç firması Sanofi Aventis' in aşı bölümü Sanofi Pasteur' den ALVAC ve orijinali şu anda kâr amacı gütmeyen Global Solutions for Infectious Diseases örgütüne ait olan ABD merkezli VaxGen Inc . tarafından geliştirilen AIDSVAX - kullanıldı .

Front	Two vaccines -- ALVAC from Sanofi Pasteur , the vaccine division of French drug company Sanofi Aventis , and AIDSVAX , originally developed by US-based VaxGen Inc. that is now owned by the non-profit Global Solutions for Infectious Diseases -- were used in the trial that targeted HIV strains circulating in Thailand .
Back	Tayland' da dolaşan HIV türlerini hedef alan deneyde iki aşı - Fransız ilaç firması Sanofi Aventis' in aşı bölümü Sanofi Pasteur' den ALVAC ve orijinali şu anda kâr amacı gütmeyen Global Solutions for Infectious Diseases örgütüne ait olan ABD merkezli VaxGen Inc . tarafından geliştirilen AIDSVAX - kullanıldı .

Sanofi Alvac Aidsvax Vaxgen Global Solutions Infectious Diseases